4-aminobenzoic acid has been researched along with Chronic Bronchitis in 1 studies
para-Aminobenzoates: Benzoic acids, salts, or esters that contain an amino group attached to carbon number 4 of the benzene ring structure.
4-aminobenzoate : An aromatic amino-acid anion that is the conjugate base of 4-aminobenzoic acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We aimed to characterise the whole genome gene expression profile of the inhaled PDE4-inhibitor CHF6001 on top of triple therapy in sputum cells and whole blood of patients with COPD and chronic bronchitis." | 9.34 | Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis. ( Afolabi, EK; Bassi, M; Beeh, KM; Colgan, B; Emirova, A; Govoni, M; Jellema, GL; Kornmann, O; Leaker, B; Lucci, G; Nandeuil, MA; Petruzzelli, S; Singh, D; Vezzoli, S; Watz, H, 2020) |
| " We aimed to characterise the whole genome gene expression profile of the inhaled PDE4-inhibitor CHF6001 on top of triple therapy in sputum cells and whole blood of patients with COPD and chronic bronchitis." | 5.34 | Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis. ( Afolabi, EK; Bassi, M; Beeh, KM; Colgan, B; Emirova, A; Govoni, M; Jellema, GL; Kornmann, O; Leaker, B; Lucci, G; Nandeuil, MA; Petruzzelli, S; Singh, D; Vezzoli, S; Watz, H, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Govoni, M | 1 |
| Bassi, M | 1 |
| Vezzoli, S | 1 |
| Lucci, G | 1 |
| Emirova, A | 1 |
| Nandeuil, MA | 1 |
| Petruzzelli, S | 1 |
| Jellema, GL | 1 |
| Afolabi, EK | 1 |
| Colgan, B | 1 |
| Leaker, B | 1 |
| Kornmann, O | 1 |
| Beeh, KM | 1 |
| Watz, H | 1 |
| Singh, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomised, Double-blind,Placebo Controlled, Repeated Dose, Three-way Crossover Study to Evaluate the Pharmacodynamics, Pharmacokinetics and Safety of Two Doses of CHF6001 DPI in Subjects With Moderate, Severe COPD[NCT03004417] | Phase 2 | 61 participants (Actual) | Interventional | 2016-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for 4-aminobenzoic acid and Chronic Bronchitis
| Article | Year |
|---|---|
Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis.
Topics: Administration, Inhalation; Aged; Anti-Inflammatory Agents; Biomarkers; Bronchitis, Chronic; Cross-O | 2020 |